| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 40.89B | 40.16B | 40.20B | 39.89B | 37.69B | 37.27B |
| Gross Profit | 8.55B | 8.40B | 8.59B | 8.00B | 7.21B | 7.34B |
| EBITDA | 2.54B | 2.00B | 2.41B | 1.74B | 1.22B | 1.13B |
| Net Income | 1.76B | 1.32B | 1.66B | 949.00M | 474.00M | 500.00M |
Balance Sheet | ||||||
| Total Assets | 27.11B | 27.56B | 26.57B | 24.16B | 23.59B | 21.19B |
| Cash, Cash Equivalents and Short-Term Investments | 1.22B | 1.15B | 1.46B | 1.25B | 1.18B | 1.35B |
| Total Debt | 13.70B | 13.34B | 13.66B | 14.48B | 14.91B | 13.69B |
| Total Liabilities | 18.23B | 18.77B | 18.96B | 19.51B | 20.16B | 18.52B |
| Stockholders Equity | 8.88B | 8.79B | 7.61B | 4.65B | 3.43B | 2.67B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 588.00M | 1.19B | 538.00M | -1.53B | 1.93B |
| Operating Cash Flow | 0.00 | 662.00M | 1.31B | 598.00M | -1.29B | 2.12B |
| Investing Cash Flow | 0.00 | -5.00M | -84.00M | -70.00M | -264.00M | -224.00M |
| Financing Cash Flow | 0.00 | -1.01B | -1.03B | -484.00M | 1.35B | -1.72B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥195.25B | 15.80 | 8.27% | 2.68% | -2.45% | 7.31% | |
75 Outperform | ¥11.04B | 6.09 | ― | 3.84% | 5.86% | 44.77% | |
75 Outperform | ¥157.08B | 13.38 | ― | 2.66% | -1.63% | 67.13% | |
73 Outperform | ¥261.72B | 13.86 | ― | 3.90% | 2.65% | 7.16% | |
72 Outperform | ¥4.44B | 9.99 | ― | 2.79% | 3.32% | 18.84% | |
67 Neutral | ¥15.76B | 31.07 | ― | 2.41% | -4.23% | -5.96% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |